|
ZNF583 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.52897702779364E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.18309806396155E-11 |
| Normal-vs-Stage2 |
2.777099994411E-09 |
| Normal-vs-Stage3 |
5.22510001932375E-09 |
| Normal-vs-Stage4 |
6.81140033265137E-10 |
| Stage1-vs-Stage2 |
3.622400E-01 |
| Stage1-vs-Stage3 |
3.002000E-01 |
| Stage1-vs-Stage4 |
4.914200E-02 |
| Stage2-vs-Stage3 |
9.920400E-01 |
| Stage2-vs-Stage4 |
1.466000E-01 |
| Stage3-vs-Stage4 |
2.137600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.22102328248275E-12 |
| Normal-vs-AfricanAmerican |
2.71309996691116E-09 |
| Normal-vs-Asian |
5.98210000000154E-05 |
| Caucasian-vs-AfricanAmerican |
4.538600E-01 |
| Caucasian-vs-Asian |
7.185000E-01 |
| AfricanAmerican-vs-Asian |
5.689800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.38509999994641E-06 |
| Male-vs-Female |
7.755200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.59700000019237E-07 |
| Normal-vs-Extreme_Weight |
1.63180580159406E-12 |
| Normal-vs-Obese |
2.80739997915447E-09 |
| Normal-vs-Extreme_Obese |
3.098500E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.125700E-02 |
| Normal_Weight-vs-Obese |
7.961400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.863000E-01 |
| Extreme_Weight-vs-Obese |
2.021600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.950600E-01 |
| Obese-vs-Extreme_Obese |
4.668800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.76670000032686E-08 |
| Normal-vs-Age(41-60Yrs) |
1.70599978588371E-10 |
| Normal-vs-Age(61-80Yrs) |
3.55049323275125E-13 |
| Normal-vs-Age(81-100Yrs) |
1.49450000153095E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.227400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.519200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.217200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.434200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.660560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.001800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.5862645358643E-12 |
| Normal-VS-Type2 PRCC |
2.06656913803727E-12 |
| Normal-VS-KIRP CIMP |
6.49900000482262E-08 |
| Normal-VS-Unclassified PRCC |
3.51389999997398E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.499790E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.740350E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.365000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.377200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.315620E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.693810E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.88178419700125E-16 |
| Normal-vs-N1 |
1.06870000005088E-06 |
| Normal-vs-N2 |
6.51120000139116E-08 |
| N0-vs-N1 |
1.689380E-01 |
| N0-vs-N2 |
1.773580E-02 |
| N1-vs-N2 |
3.350300E-02 |
|
|
